Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis

NCT ID: NCT01837056

Last Updated: 2013-04-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

98 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2012-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigate the prevalence of Toxoplasma gondii and Toxocara canis in Uveitis

* serum antibody to T. gondii and T. canis
* PCR with peripheral blood for T. gondii and T. canis
* PCR with aqueous humor for T. gondii and T. canis
* Clinical manifestation of patient with uveitis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Consecutive patients with uveitis are enrolled in Nune Eye Hospital.

Serum ELISA

* IgM,IgG antibody to Toxoplasma gondii
* IgG antibody to Toxocara canis

PCR

* PCR with serum and aqueous humor to Toxoplasma gondii
* PCR with serum and aqueous humor to Toxocara canis Clinical characteristics
* visual acuity
* intraocular pressure (IOP)
* location and degree of inflammation
* other fundus findings were recorded

questionnaire

* environment, occupation
* pet ownership, exposure to animal
* history of eating raw liver of animal, raw beef or any other raw flesh of animal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Uveitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with uveitis

Exclusion Criteria

* Patients with history of major ophthalmic surgery within 6 months
* antiviral, antifungal or antiparasitic therapy within 6 months
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Health, Korea

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lim, Su Jin

The retina staff

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Su Jin Lim, MD

Role: PRINCIPAL_INVESTIGATOR

Nune Eye Hospital

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Nuneuveitis

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Primary Tube Versus Trabeculectomy Study
NCT00666237 COMPLETED PHASE4
Glaucoma Evaluation With the P200TE
NCT06305481 RECRUITING NA